Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Journal of Comparative Effectiveness Research|November 19, 2013
90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectivenessMinzhi Xing, Nima Kokabi, Juan C Camacho, et al.
Cancer Letters|January 14, 2025
Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategiesGanji Purnachandra Nagaraju, Tatekalva Sandhya, Mundla Srilatha, et al.
The Oncologist|November 29, 2018
High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database StudyOlatunji B Alese, Renjian Jiang, Walid Shaib, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 2, 2025
CRISPR/Cas9-directed epigenetic editing in colorectal cancerManoj Kumar Gupta, Gayatri Gouda, Maryam Moazzam-Jazi, et al.
Journal of Surgical Oncology|April 25, 2014
Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based reviewMinzhi Xing, David A Kooby, Bassel F El-Rayes, et al.
Journal of Cellular Biochemistry|March 10, 2010
Concurrent inhibition of NF-kappaB, cyclooxygenase-2, and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancerShadan Ali, Sanjeev Banerjee, Jacqueline M Schaffert, et al.
Cancer Medicine|January 17, 2015
Open pipelines for integrated tumor genome profiles reveal differences between pancreatic cancer tumors and cell linesJeremy Goecks, Bassel F El-Rayes, Shishir K Maithel, et al.
Life Sciences|March 28, 2009
Protein kinases C isozymes are differentially expressed in human breast carcinomasShadan Ali, Sana Al-Sukhun, Bassel F El-Rayes, et al.
Dalton Transactions (Cambridge, England : 2003)|December 25, 2013
Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3 mesoporous particlesG Seeta Rama Raju, E Pavitra, Ganji Purnachandra Nagaraju, et al.
Pageof 20